The production value of basic pharmaceutical products in Italy is forecasted to increase consistently over the next five years. From a baseline in 2023, where the production value stood, 2024 will see a forecasted value of 6.12 billion euros. This figure is set to grow to 6.75 billion euros by 2028. Year-on-year percentage variations show steady growth: 2.61% from 2024 to 2025, 2.55% from 2025 to 2026, 2.48% from 2026 to 2027, and 2.27% from 2027 to 2028. The Compound Annual Growth Rate (CAGR) over this period is approximately 2.48%, indicating a stable upward trend.
Future trends to watch include:
- Technological advancements and innovation in drug development.
- Regulatory changes and their potential impact on production costs.
- Global supply chain dynamics and their influence on Italy's market position.
- Healthcare demand driven by an aging population.
- Potential market consolidation through mergers and acquisitions.
